Dolby Laboratories, Inc.
DLB
$65.27
$1.081.68%
NYSE
| 06/26/2026 | 03/27/2026 | 12/26/2025 | 09/26/2025 | 06/27/2025 | |
|---|---|---|---|---|---|
| Net Income | 28.60M | 94.92M | 53.33M | 49.33M | 46.07M |
| Total Depreciation and Amortization | 25.07M | 26.85M | 26.81M | 24.58M | 24.40M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 23.24M | 42.83M | 31.21M | 61.10M | 29.59M |
| Change in Net Operating Assets | 90.55M | -72.09M | -56.55M | -12.17M | -32.37M |
| Cash from Operations | 167.46M | 92.51M | 54.80M | 122.83M | 67.69M |
| Capital Expenditure | -14.99M | -9.06M | -4.63M | -16.24M | -6.43M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.20M | -37.03M | 5.87M | -5.67M | 0.00 |
| Cash from Investing | -9.79M | -46.09M | 1.25M | -21.91M | -6.43M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 9.39M | 1.04M | 14.25M | 5.02M | 12.56M |
| Repurchase of Common Stock | -65.89M | -66.03M | -101.20M | -37.08M | -41.20M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -33.99M | -34.34M | -34.34M | -31.59M | -31.63M |
| Other Financing Activities | -534.00K | -559.00K | -547.00K | -398.00K | -468.00K |
| Cash from Financing | -91.02M | -99.88M | -121.83M | -64.06M | -60.74M |
| Foreign Exchange rate Adjustments | -1.58M | -301.00K | -5.00K | -67.00K | 5.70M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 65.08M | -53.76M | -65.80M | 36.80M | 6.22M |